期刊文献+

系统性红斑狼疮并发类固醇糖尿病患者临床特点和危险因素分析 被引量:2

Clinical characteristics and risk factors of steroid diabetes mellitus in patients with systemic lupus erythematosus
原文传递
导出
摘要 目的分析系统性红斑狼疮(SLE)并发类固醇糖尿病(SDM)患者的临床特点和危险因素。方法回顾性分析2006年2月至2013年6月在广州医科大学附属第二医院住院的14例并发SDM的SLE患者临床资料,并与性别、发病年龄相匹配的100例无合并SDM的SLE患者比较。结果 14例SLE合并SDM患者中男1例,女13例,平均年龄(48.0±10.3)岁。4例SDM患者出现"三多一少"症状,4例空腹和餐后血糖均升高,10例餐后血糖升高。SDM患者使用口服降血糖药和(或)胰岛素治疗。单因素比较发现,SLE并发SDM组患者关节炎、肾脏病变、高血压、高胆固醇血症、高甘油三酯血症、高尿酸血症患者增多,差异有统计学意义(P〈0.05)。多因素Logistic回归分析显示,高胆固醇血症是SLE患者并发SDM独立危险因素(OR 12.942,95%CI:2.994~41.316,P=0.000)。结论 SLE患者并发SDM患者关节炎、肾脏病变、高血压、高胆固醇血症、高甘油三酯血症、高尿酸血症者增多,高胆固醇血症是SLE患者并发SDM独立危险因素。 ObjectiveTo analyzeclinical characteristics and risk factors of steroid diabetes mellitus (SDM) in patients with systemic lupus erythematosus (SLE).MethodsFourteen medical records of SLE patients with SDM and 100 randomly-matched records of SLE patients without SDM were reviewed, the clinical data were compared between the two groups.Results Fourteen patients with SLE complicating with SDM included 1 man and 13 women, with the mean age of (48.0±10.3)years. Four patients of them had diuresis, polydipsia, polyphagia or maransis. Four patients with SDM had high fasting blood glucose and high postprandial blood glucose, and ten patients with SDM had high postprandial blood glucose. Hypoglycemic drugs and/or insulin were prescribed for patients with SDM. There was significant difference between SLE patients with SDM and SLE patients without SDM in arthritis, nephropathy, hypertension, hypercholesterolemia, hypertriglyceridemia, hyperuricemia (P〈0.05). Hypercholesterolemia was an independent risk factor for SDM in SLE patients(OR 12.94, 95%CI 2.994-41.316,P=0.000). ConclusionsThere is an increased rate for SLE patients with SDM in arthritis, nephropathy, hypertension, hypercholesterolemia, hypertriglyceridemia and hyperuricemia. Hypercholesterolemia is an independent risk factor for SDM in SLE patients.
作者 王卓龙 陶怡
出处 《中华临床医师杂志(电子版)》 CAS 2014年第22期51-54,共4页 Chinese Journal of Clinicians(Electronic Edition)
关键词 红斑狼疮 系统性 危险因素 类固醇糖尿病 Lupus erythematosus, systemic Risk factors Steroid diabetes mellitus
  • 相关文献

参考文献16

  • 1Rahman A,Isenberg DA.Systemic lupus erythematosus[J].N Engl J Med,2008,358(9):929-939.
  • 2Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
  • 3邹伏英,王友莲.类固醇糖尿病的诊断与治疗进展[J].中华风湿病学杂志,2013,17(8):564-566. 被引量:20
  • 4Cortes S,Chambers S,Jerónimo A,et al.Diabetes mellitus complicating systemic lupus erythematosus-analysis of the UCL lupus cohort and review of the literature[J].Lupus,2008,17(11):977-980.
  • 5刘敏,李彩凤,李文京.儿童1型糖尿病合并系统性红斑狼疮一例报告[J].中华糖尿病杂志(1006-6187),2005,13(3):233-233. 被引量:4
  • 6赖建铭,吴凤岐,周志轩.儿童系统性红斑狼疮合并糖尿病4例及远期随访[J].中国循证儿科杂志,2010,5(1):51-54. 被引量:4
  • 7陈惠萍,刘志红,陈瑜.2型糖尿病合并狼疮性肾炎[J].肾脏病与透析肾移植杂志,2004,13(2):192-195. 被引量:2
  • 8Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1997,40(9):1725.
  • 9Alberti KG,Zimmet PZ.Definition,diagnosis,and classification of diabetes mellitus and its complications:report of a WHO consultation.PartⅠ:diagnosis and classification of diabetes mellitus[J].Diabet Med,1998,15(7):539-553.
  • 10Tsokos GC.Systemic lupus erythematosus[J].N Engl J Med,2011,365(22):2110-2121.

二级参考文献96

  • 1刘敏,李彩凤,李文京.儿童1型糖尿病合并系统性红斑狼疮一例报告[J].中华糖尿病杂志(1006-6187),2005,13(3):233-233. 被引量:4
  • 2Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol, 1997, 145: 408-415.
  • 3Ward MM. Premature morbidity from cardiovascular and cardiovascular disease in women with SLE. Arthritis Rheum, 1999, 42: 338-346.
  • 4Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlated atherosclerosis in systemic lupus erythematosus. N Engl J Med, 2003, 349: 2399-2406.
  • 5Sergio D, Luis AG, Graciela SA. Damage, accelerated atherosclerosis, and mortality in patients with systemic lupus crythematosus. J Clin Rheumato, 2007, 13:350 -353.
  • 6Vlachoyiannopoulos PG, Kanellopoulos PG, Loannidis JPA, et al. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology, 2003, 42:645-651.
  • 7Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis, 2003, 62: 1071-1077.
  • 8Assmann G, Cannena R, Cullen P, et al. Coronary heart disease: reducing the risk a world wide view. Circulation, 1999, 100: 1930-1938.
  • 9Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum, 2001, 44: 2331-2337.
  • 10Mary J, Mary K, Michael D, et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum, 2007, 10: 3412-3419.

共引文献64

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部